Status:
COMPLETED
Evaluating the Need for New Rhinitis Treatment
Lead Sponsor:
Research in Real-Life Ltd
Collaborating Sponsors:
Meda Pharmaceuticals
Conditions:
Rhinitis
Eligibility:
All Genders
Brief Summary
The proposed study will evaluate the unmet therapy need in seasonal rhinitis by aiming to answer the following research questions 1. What is the first prescription of the hay-fever season and how man...
Detailed Description
Allergic rhinitis is a chronic respiratory disease with a major impact on quality of life. In a study looking at the burden of allergic rhinitis amongst UK patients 75% reported some impact of their a...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- The analysis will include patients who, at the index date, receive a therapy prescription for allergic rhinitis and have been diagnosed with a hay fever read code during their time at the practice. The following patients will be included within the study population:
- (i)Patients receiving therapy: defined as those with a prescription for the increase or initiation of hay fever therapy during the hay fever season
- (ii)Hay-fever code recorded ever
- Exclusion criteria
- (i)Patients taking maintenance oral steroids during the baseline period
- (ii)Patients who only received LTRA during the study period and had already been receiving LTRA previously
Exclusion
Key Trial Info
Start Date :
January 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2013
Estimated Enrollment :
21203 Patients enrolled
Trial Details
Trial ID
NCT01875276
Start Date
January 1 2013
End Date
March 1 2013
Last Update
June 11 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Research in Real Life Ltd
Cambridge, United Kingdom, CB24 3BA